Table 1.
Patient characteristics.
| Variable | N = 191 |
|---|---|
| Demographics and comorbid conditions 1 | |
| Mean age (±SD), years | 52.6 (16.0) |
| Male, n (%) | 91 (47.6) |
| Type 2 diabetes mellitus, n (%) | 41 (21.5) |
| Essential hypertension, n (%) | 60 (31.4) |
| Chronic kidney disease, n (%) | 11 (5.8) |
| Previous stroke, n (%) | 5 (2.1) |
| Dengue virus serotype, n/N (%) | |
| Serotype 1 | 5/90 (5.6) |
| Serotype 2 | 63/90 (70) |
| Serotype 3 | 22/90 (24.4) |
| Serotype 4 | 0 |
| Dengue severity, n (%) | |
| 1997 WHO classification | |
| DF | 122 (63.9) |
| Nonshock DHF | 63 (32.9) |
| DSS | 6 (3.1) |
| 2009 WHO classification | |
| Nonsevere dengue | 176 (92.1) |
| Severe dengue | 15 (7.9) |
| Clinical features at hospital presentation 2 | |
| Mean day from onset illness to presentation (±SD) | 3.4 (1.7) |
| Fever, n (%) | 182 (95.3) |
| Abdominal pain, n (%) | 47 (24.6) |
| Orbital pain, n (%) | 26 (13.6) |
| Bone pain, n (%) | 69 (36.1) |
| Myalgia, n (%) | 104 (54.5) |
| Headache, n (%) | 67 (35.1) |
| Rashes, n (%) | 38 (20) |
| Vomiting/nausea, n (%) | 47 (24.6) |
| Diarrhea, n (%) | 43 (22.5) |
| Petechial, n (%) | 40 (20.9) |
| Cough, n (%) | 47 (24.6) |
| Dizziness, n (%) | 43 (22.5) |
| Gastrointestinal bleeding, n (%) | 15 (7.9) |
| Gum bleeding, n (%) | 23 (12) |
| Laboratory features and outcome | |
| Leukopenia (WBC < 3.0 × 109 cells/L), n (%) | 57 (29.8) |
| Mean hematocrit (±SD) (%), (n) | 41 ± 4.5 (n = 164) |
| Mean platelet count (±SD) (×109 cells/L), (n) | 62.6 ± 45.1 (n = 189) |
| Mean CRP (±SD) mg/L | 19.3 (27.6) |
| Fatality, n (%) | 3 (1.6) |
CRP = C-reactive protein; DF = dengue fever; DHF = dengue hemorrhagic fever; DSS = dengue shock syndrome; WBC = white blood cell count; WHO = World Health Organization.
1An individual patient might have more than one underlying disease/condition.
2An individual patient might have more than one symptom and/or sign.